Contrasting effects of thiol-modulating agents on endothelial NO bioactivity (Q43666388)

25 November 2017

title

Contrasting effects of thiol-modulating agents on endothelial NO bioactivity (English)

1 reference

25 November 2017

0 references

4

1 reference

25 November 2017

Huang A

1

1 reference

25 November 2017

Xiao H

series ordinal

2

1 reference

25 November 2017

Samii JM

series ordinal

3

1 reference

25 November 2017

Keaney JF Jr

series ordinal

5

1 reference

25 November 2017

publication date

1 August 2001

1 reference

American Journal of Physiology - Cell Physiology

25 November 2017

published in

1 reference

25 November 2017

volume

281

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

C719-25

1 reference

Endothelium-dependent inhibition of platelet aggregation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Functional modulation of ANF-sensitive particulate guanylate cyclase by redox mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Role of intracellular thiols in release of EDRF from cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Vasodilatory properties of recombinant maxadilan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Role of endothelium-derived nitric oxide in the regulation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.2001.281.2.C719

10.1152/AJPCELL.2001.281.2.C719

21 January 2018

Identifiers

DOI

0 references

1 reference